Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Number of holders
-
1,091
-
Total 13F shares, excl. options
-
222,498,992
-
Shares change
-
-3,511,700
-
Total reported value, excl. options
-
$67,185,310,864
-
Value change
-
-$895,364,531
-
Put/Call ratio
-
103%
-
Number of buys
-
463
-
Number of sells
-
488
-
Price
-
$302.03
Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2019
As of 31 Dec 2019 Elevance Health, Inc. - Common Stock (ELV) had 1,091 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 222,498,992 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Capital International Investors, Invesco Ltd., BAILLIE GIFFORD & CO, and TCI FUND MANAGEMENT LTD.
This table shows 1,092 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.